首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 0 毫秒
1.
目的:观察不同频率电针对慢传输型便秘(STC)模型大鼠肠道传输功能、结肠肌电、结肠一氧化氮合酶(NOS)含量和大鼠Cajal间质细胞(ICC)表达的影响.方法:选择健康雄性Wistar大鼠50只,随机选取10只为正常组,饲以普通饲料,其余40只在饲料中添加复方苯乙哌啶,剂量为每日8 mg/(kg·bw),连续给药120 d,40只大鼠均成功建立STC大鼠模型,并随机分为模型组、低频电针组(频率为2 Hz)、高频电针组(频率为100 Hz)和变频电针组(频率为2 Hz/100 Hz),每组10只.正常组和模型组不进行任何治疗,低频电针组和高频电针组分别给予相应频率的连续波电针刺激天枢、足三里和支沟,变频电针组接受相应频率的疏密波电针刺激相同穴位,每日1次,共治疗15 d.治疗后测定各组大鼠肠道传输功能、结肠肌电、结肠NOS含量和结肠C-kit阳性细胞面积,以面积的数值差异来表示ICC的表达.结果:在肠道传输功能方面,与正常组大鼠比较,其余各组大鼠首粒黑便排出时间均明显延长(均P<0.05);与模型组比较,三个电针组大鼠首粒黑便排出时间明显缩短(均P<0.05);变频电针组首粒黑便排出时间明显短于低频电针组和高频电针组(均P<0.05).在结肠肌电方面,与正常组大鼠比较,其余各组大鼠结肠肌电振幅明显变大,频率加快(均P<0.05);与模型组比较,三个电针组的振幅明显缩小,频率减慢(均P<0.05);与低频电针组和高频电针组比较,变频电针组振幅缩小,频率明显降低(均P<0.05).结肠NOS含量方面,与正常组大鼠比较,其余各组大鼠NOS含量明显增加(均P<0.05);与模型组比较,三个电针组NOS含量明显降低(均P<0.05);与低频电针组和高频电针组比较,变频电针组NOS含量明显降低(均P<0.05).各组大鼠结肠C-kit阳性细胞面积方面,与正常组大鼠比较,其余各组大鼠C-kit阳性细胞面积明显减少(均P<0.05).与模型组比较,三个电针组C-kit阳性细胞面积明显增加(均P<0.05);与低频电针组比较,变频电针组C-kit阳性细胞面积明显增大(P<0.05).结论:电针,特别是2 Hz/100 Hz变频电针治疗STC模型大鼠疗效肯定,可能是通过调节大鼠结肠肌电、结肠NOS含量和ICC表达改善其肠道功能.  相似文献   

2.
目的:观察穴位埋线疗法对慢传输型便秘(STC)患者临床疗效及其对结肠传输功能、血浆P物质(SP)、血管活性肠肽(VIP)的影响。方法收集2012年3月至2013年1月青岛市黄岛中医院、青岛市海慈医疗集团、青岛大学医学院附属医院的STC患者128例,采用随机数表法将患者随机分为两组各64例。治疗组采用穴位埋线治疗,对照组口服乳果糖口服液治疗,疗程均为4周。观察两组患者治疗前后的临床疗效及对结肠传输功能、SP、VIP 的影响。结果治疗组治疗前便秘评分量表(CCS)评分为(13.52±3.93)分、治疗后为(8.15±3.77)分;对照组治疗前为(14.11±4.24)分、治疗后为(9.01±2.93)分,两组治疗后 CCS 评分均较同组治疗前降低(P<0.01),但组间比较差异无统计学意义(P>0.05)。治疗后两组血浆SP、VIP水平[治疗组分别为(46.73±1.50)ng/L、(206.10±12.14)ng/L,对照组分别为(40.92±6.25)ng/L、(214.73±7.62)ng/L]均较同组治疗前[治疗组分别为(26.66±0.88)ng/L、(332.68±17.84)ng/L,对照组分别为(23.32±1.75)ng/L、(306.22±20.01)ng/L]改善,差异有统计学意义(P<0.05),且两组比较,血浆SP、VIP水平差异均有统计学意义(P<0.05)。结论穴位埋线疗法可改善STC患者的临床症状及结肠传输功能,并可能通过调节血SP、VIP水平达到治疗效果。  相似文献   

3.
目的观察芪榔合剂对慢传输型便秘小鼠结肠Cajal间质细胞的影响,探讨其通便机制。方法用复方地芬诺酯制作实验性便秘小鼠模型,造模成功后随机分为便秘模型组、中药大剂量组、中药小剂量组,并设正常对照组,给予相应干预措施,共干预15天。观察小鼠排便时间、炭末推进率;光镜观察小鼠结肠Cajal细胞结构、免疫组化法观察小鼠结肠c-kit阳性表达及小鼠结肠c-kitmRNA阳性表达。结果与正常对照组比较,模型组首次排便时间明显延长,8 h、20 h排便总数明显减少,不排便动物数明显增多,小肠炭末推进率明显降低,结肠c-Kit阳性细胞数、c-kit mRNA表达率明显减少,差异均有统计学意义(P<0.05,P<0.01),说明造模成功;与模型组比较,中药大小剂量组首次排便时间明显缩短,8 h、20 h排便总数明显增多,小肠炭末推进率明显升高,结肠c-Kit阳性细胞数、c-kit mRNA表达率明显增加,差异均有统计学意义(P<0.05,P<0.01)。光镜下显示,与正常对照组比较,模型组Cajal间质细胞出现基膜溶解,数量减少,其与周围细胞之间的紧密连接也被破坏,细胞核有不同程度萎缩;与模型组比较,中药大小剂量组的Cajal间质细胞数量增加。结论芪榔合剂具有较好促进小鼠肠动力的作用,其通便机制可能为通过促进Cajal细胞的再生及修复而达到促进肠动力,从而实现通便的作用。  相似文献   

4.
目的探讨白术生地颗粒治疗慢通过型便秘模型动物后肌间神经丛的P物质(SP)、血管活性肠肽(VIP)神经递质的表达及意义。方法制作慢通过型便秘大鼠模型,使用白术生地颗粒进行实验干预,观察分析不透X线标记物胃肠通过时间,检查大便颗粒及重量变化。并采用免疫组化S-P法对其近端结肠、远端结肠肌间神经丛的SP、VIP递质进行检测。结果干预组排便粒数较模型组、自然恢复组明显增加。干预组大鼠不同节段肠肌间神经丛递质的表达,与自然恢复组比较,SP近端结肠增加,远端结肠无显著性差异;VIP近端结肠降低,远端结肠增加;与模型持续组比较,VIP近端结肠降低,远端结肠增加;近端结肠及远端结肠SP皆增加。结论白术生地颗粒可增加慢通过型便秘动物模型结肠黏膜下VIP、SP神经递质含量,对结肠蠕动有调节作用,对改善收缩波远端的肠段平滑肌舒张,近端肠段平滑肌维持收缩的协调性有重要意义。  相似文献   

5.
枳术丸对慢传输型便秘大鼠的影响   总被引:1,自引:0,他引:1  
目的探讨枳术丸挥发油对慢传输型便秘(slow transit constipation,STC)大鼠的治疗作用及可能的作用机理。方法应用盐酸吗啡制作STC模型大鼠,采用活性炭悬液推进法测定枳术丸挥发油干预前后STC模型大鼠肠道推进功能,并采用在体结肠肌电测定法测定枳术丸挥发油干预前后STC模型大鼠结肠的肌电活动情况。结果与模型对照组相比,枳术丸挥发油组的STC大鼠肠道推进率增加(P0.05),结肠慢波振幅减小(P0.05)、频率加快(P0.05),振幅及频率变异系数均减小(P0.05)。结论枳术丸挥发油可增强STC结肠推进功能,其治疗作用机制之一是纠正STC异常的结肠慢波。  相似文献   

6.

Objective

To explore the effects of different acupuncture-moxibustion methods on the plasma substance P (SP) content, and the expression of colonic SP mRNA of the rats with functional constipation.

Methods

Sixty healthy male SD rats were divided into six groups according to the random number table, including blank control group (group B, n=8), model group (group M, n=11), drug control group (group D, n=8), filiform needle group (group F, n=11), electroacupuncture group (group E, n=11) and moxibustion group (group MB, n=11). The rats in group B and group M accepted no intervention, gavage with cisapride suspension was conducted in group D, and electroacupuncture, filiform needling and moxibustion therapies were carried out in group E, group F and group MB for 6 days. After treatment, the stool quantity and fecal moisture content during 24 h of the rats were observed in each group, colon tissue structure and the acidic mucus in mucosa layer were observed, plasma SP content was detected and the expression of colonic SP mRNA was detected.

Results

Compared with group B, the stool quantity and fecal moisture content during 24 h of the rats in group M decreased significantly (P<0.01); compared with group M, the stool quantity during 24 h of the rats in each group increased (P<0.05 or 0.01), and the fecal moisture content during 24 h of the rats in each group also increased significantly except group MB (P<0.01); compared with group D, the fecal moisture content during 24 h of the rats in group MB decreased (P<0.01); according to the comparison among the groups with different acupuncture-moxibustion methods, there was no difference in the stool quantity during 24 h of the rats in each group (P>0.05), the fecal moisture contents during 24 h of the rats in group F and group E were higher than that of group MB (P<0.01), and there was no difference between group F and group E (P>0.05). HE staining of colon tissue of rats showed that the structure was normal and complete, and there was no difference among each group. PAS staining showed that the acidic mucus level of the rats in group M decreased significantly when compared with group B; compared with group M, the acidic mucus level of the rats in group D, fgroup F, group E and group MB increased in varying degrees. Compared with group B, the plasma SP content of the rats in group M decreased (P<0.05); compared with group M, the plasma SP contents of the rats in group F and group MB increased (P<0.01); the plasma SP contents of the rats in group F, group MB and group E were higher than that of group D (P<0.05 or 0.01); according to the comparison among the groups with different acupuncture-moxibustion methods, the plasma SP content of the rats in group F was higher than that of group MB and electro-acupuncture group (P<0.05), and there was no difference between group MB and group E. Compared with group B, the expression level of colonic SP mRNA of the rats in group M elevated (P<0.05); compared with group M, the expression level of colonic SP mRNA of the rats in the four intervention groups declined (P<0.05); compared with drug group D, there was no difference among group F, group E and group MB (P>0.1); according to the comparison among the groups with different intervention methods, the expression level of colonic SP mRNA of the rats in group MB was lower than that of group F (P<0.05).

Conclusion

The different efficacy of different acupuncture-moxibustion methods in treatment of functional constipation may be related with the mechanism of regulation of plasma SP content and the expression level of colonic SP mRNA.  相似文献   

7.
目的观察电针八髎穴及承山穴治疗慢传输型便秘的临床疗效。方法将58例慢传输型便秘患者随机分为观察组30例和对照组28例,观察组给予电针八髎穴及承山穴治疗,对照组给予枸橼酸莫沙必利片口服,2组疗程均为20 d,观察对比2组治疗前后及随访时的各主要症状积分及总积分。结果观察组显愈率高于显著对照组(P<0.05)。2组在疗程结束时积分均比治疗前明显下降(P均<0.05),结肠传输试验均明显改善(P均<0.05),但2组间比较差异无统计学意义;在治疗结束3个月后随访时发现,观察组主要症状评分及总评分、结肠传输试验结果均好于对照组(P均<0.05)。结论电针八髎穴及承山穴治疗慢传输型便秘疗效满意。  相似文献   

8.
天枢穴深刺治疗结肠慢转运性便秘的理论浅析   总被引:2,自引:0,他引:2  
结肠慢转运性便秘属于难治性便秘,约占便秘患者的15%。该病目前无特效治疗方法。本文通过查阅古代及现代有关资料,对天枢穴深刺治疗结肠慢转运性便秘的理论进行分析,说明该疗法的可行性。  相似文献   

9.
目的:探讨肠舒颗粒对腹泻型肠易激综合征(IBS)大鼠血中血管活性肠肽(VIP)、P物质(SP)的影响。方法:将40只大鼠随机分为空白组、模型组、肠舒颗粒组、氯化钠注射液组、模型组。采用"精神刺激+饮食失宜+劳倦"方法建立肝郁脾虚型IBS动物模型。模型建立后,空白组、模型组给予正常喂养,肠舒颗粒组与氯化钠注射液组分别给予相应药物灌胃。采用酶联免疫法测定血中VIP、SP水平。结果:模型组VIP、SP水平高于空白组、肠舒颗粒组(P0.05或P0.01);肠舒颗粒组与空白组比较,差异无统计学意义(P0.05);但与氯化钠注射液组比较,差异有统计学意义(P0.05)。结论:肠舒颗粒通过减少胃肠激素分泌释放而抑制IBS(腹泻型)的肠运动功能,为临床治疗腹泻型IBS提供了实验依据。  相似文献   

10.
Sun JH  Guo H  Chen L  Wu XL  Li H  Pei LX  Peng YJ  Lu B 《针刺研究》2011,36(3):171-175
目的:观察电针"天枢"穴对慢传输型便秘(STC)大鼠结肠平滑肌结构及Cajal间质细胞(ICC)的影响,探讨电针"天枢"穴治疗STC的作用机制。方法:56只Wistar大鼠,雌雄各半,随机选20只为正常组。饲喂复方苯乙哌啶饲料建立STC大鼠模型。造模成功的大鼠分为电针组和模型组,每组18只。电针组电针双侧"天枢"穴15 min,连续治疗14 d。采用HE染色法及免疫组化法观察各组大鼠结肠肠壁形态结构及结肠ICC的表达。结果:①HE染色中模型组大鼠肠黏膜的腺体萎缩,腺泡减少,分布稀疏,其平滑肌厚度与正常大鼠比较明显变薄(P<0.05);电针组大鼠结肠肠壁形态结构与正常组类似,其平滑肌厚度与模型组比较明显变厚(P<0.05)。②免疫组化染色中模型组大鼠ICC形态及分布与正常组类似,但着色较淡、模糊,网络结构不连续,其细胞计数与正常组比较明显减少(P<0.05),平均吸光度值与正常组比较明显降低(P<0.05);电针组结肠ICC数量接近正常组大鼠(P>0.05),与模型组比较明显升高(P<0.05)。结论:STC大鼠结肠功能障碍可能与结肠平滑肌结构和ICC病理改变有关。电针可使大鼠结肠肠壁平滑肌结构与ICC趋于正常,可能是其治疗STC的机制之一。  相似文献   

11.
目的:研究中药白术七物颗粒对结肠慢传输型便秘小鼠肠道传输功能的影响。方法:将60只昆明种小鼠随机分为正常组(15只)和模型组(45只)。模型组小鼠皮下注射盐酸吗啡2.5mg·kg-1·d11建立结肠慢传输型便秘(STC)模型,正常组皮下注射等量等渗生理盐水,共45d。将造模成功的40只小鼠随机分为3组:对照组(10只)、白术七物颗粒组(15只)和莫沙必利组(15只)。各组小鼠分别予以相应药物灌胃治疗,正常组和对照组小鼠予等量等渗生理盐水灌胃,每天1次,连续14d。于给药第14天计算每组小鼠当天粪便干重,末次给药后测定并对比分析各组小鼠肠道墨汁推进率。结果:治疗后各治疗组小鼠粪便干重均有不同程度增加,肠道墨汁推进率提高,且白术七物颗粒组改善程度优于莫沙必利组,差异有统计学意义(P〈0.05)。结论:白术七物颗粒能增强结肠慢传输型便秘小鼠的肠道传输功能。  相似文献   

12.
目的:观察电针天枢穴对慢传输型便秘大鼠结肠传输功能的调节,从电生理角度探讨针刺治疗慢传输型便秘的作用机制。方法:以饲喂复方苯乙哌啶饲料建立STC大鼠模型。模型大鼠分为电针组和模型组,予电针组电针双侧天枢穴,疗程14d,治疗结束后测定各组大鼠的结肠肌电活动。结果:正常组大鼠结肠慢波表现为规则的近似正弦波样曲线,频率为(14.56±4.01)次/3min,平均振幅为(0.18±0.04)mV。模型组大鼠结肠慢波则为极不规律的杂乱无章的曲线,频率、振幅分别为(23.33±6.66)次/3min,(0.26±0.04)mV,与正常组比较有显著差异性(P<0.05);电针组慢波波形接近正常组,频率为(15.89±5.34)次/3min,振幅为(0.19±0.04)mV,与正常组大鼠比较没有差异,与模型组比较有显著性差异(P<0.05)。结论:STC大鼠存在结肠慢波节律异常;电针天枢穴可能通过改善结肠慢波节律,从而改善结肠的传输功能。  相似文献   

13.
尹平  高宁阳  徐世芬  朱博畅  刘佳 《河北中医》2013,35(8):1229-1233
目的 通过观察穴位埋线对慢传输型便秘(STC)模型大鼠肠道传输功能的影响,以明确不同穴位调节STC的穴位特异性.方法 将62只SD大鼠,随机分为正常组(6只)和造模组(56只);待成功诱导实验性STC大鼠模型后,再将造模组随机分为模型组(13只)、大肠俞组(13只)、天枢组(14只)及上巨虚组(13只).其中,大肠俞组、天枢组、上巨虚组分别给予相应穴位的埋线治疗,7d治疗1次,连续治疗4次.采用活性碳灌胃法测定2、4次埋线后大鼠6h内首粒黑便排出时间、大便粒数及质量;采用活性碳推进试验测定碳推进百分率(%).结果 ①经2次埋线治疗后,大鼠6h内首粒黑便排出时间:模型组、上巨虚组、大肠俞组高于正常组(P<0.01);天枢组、上巨虚组、大肠俞组低于模型组(P<0.01);上巨虚组、大肠俞组高于天枢组(P<0.01).大鼠6h内大便粒数及质量:模型组低于正常组(P<0.05),上巨虚组、大肠俞组大便粒数低于正常组(P<0.05);天枢组高于模型组(P<0.01),上巨虚组、大肠俞组高于模型组(P<0.05);上巨虚组、大肠俞组与天枢组比较差异无统计学意义(P>0.05).碳推进百分率(%):模型组、大肠俞组低于正常组(P<0.01);天枢组高于模型组(P<0.01),上巨虚组高于模型组(P<0.05);大肠俞组低于天枢组(P<0.05),上巨虚组与天枢组比较差异无统计学意义(P>0.05).②经4次埋线治疗后,大鼠6h内首粒黑便排出时间:模型组、大肠俞组高于正常组(P<0.01),上巨虚组高于正常组(P<0.05),天枢组与正常组比较差异无统计学意义(P>0.05);天枢组、上巨虚组、大肠俞组低于模型组(P<0.01);上巨虚组、大肠俞组高于天枢组(P<0.01).大鼠6h内大便粒数及质量:模型组低于正常组(P<0.01),上巨虚组、大肠俞组大便粒数低于正常组(P<0.05);天枢组、上巨虚组、大肠俞组均高于模型组(P<0.01);大肠俞组大便粒数低于天枢组(P<0.05),上巨虚组、大肠俞组大便质量与天枢组比较差异无统计学意义(P>0.05).碳推进百分率(%):模型组、大肠俞组低于正常组(P<0.01),上巨虚组低于正常组(P<0.05);天枢组、上巨虚组、大肠俞组均高于模型组(P<0.01);大肠俞组低于天枢组(P<0.05).结论 穴位埋线治疗STC效果明确,且不同穴位调节STC存在穴位特异性,天枢更具有明确治疗STC的临床选取应用意义.  相似文献   

14.
目的观察益气活血润肠灌肠剂结合西沙比利对虚证慢传输型便秘患者肛门动力学的影响。方法将60例患者随机分为两组,治疗组30例采用益气活血润肠灌肠剂保留灌肠结合口服西沙比利治疗,对照组30例仅口服西沙比利;两组疗程均为14天,观察临床疗效及结肠运输试验、肛管直肠测压变化情况。结果①治疗组、对照组总有效率分别为83.3%、80.0%,组间临床疗效差异无统计学意义(P>0.05)。②治疗组治疗后、停药14天时与本组治疗前比较,结肠运输试验阳性率、标志物排出数及排除率差异均有统计学意义(P<0.05);治疗后与本组停药14天时比较,各指标差异均无统计学意义(P>0.05)。对照组治疗后与本组治疗前比较,各指标差异有统计学意义(P<0.05);治疗后与本组停药14天时比较,各指标差异均有统计学意义(P<0.05)。组间停药14天时比较,各指标差异均有统计学意义(P<0.05)。③治疗组治疗后、停药14天时与本组治疗前比较,直肠初始感觉阈值、直肠排便感觉阈值、直肠最大耐受量、肛管舒张压差异有统计学意义(P<0.05),对照组差异均无统计学意义(P>0.05);组间治疗后、停药14天时比较,各指标差异均有统计学意义(P<0.05)。结论益气活血润肠灌肠剂结合西沙必利具有增强肠道动力的作用,可有效用于虚证型慢传输型便秘的临床治疗。  相似文献   

15.
目的探讨针灸疗法对慢传输型便秘的临床疗效。方法通过检索、知网、万方等数据库公开发表的针灸疗法对慢传输型便秘的临床疗效的文献。探讨针灸疗法对慢传输型便秘的作用机制的临床疗效。结果针灸治疗慢传输型便秘的作用机制是否在于调节相关神经、肌肉的兴奋性达到对直肠动力与感觉的改善,其与针灸疗效的相关性如何,在目前的研究中尚没有明确答案。结论针灸治疗慢传输型便秘的作用机制主要是通过针灸调节内分泌激素,使机体产生整体非特异性效应、调节机体对结肠c-kit和SCF的基因表达、激动人体交感和副交感神经系统,改善结肠蠕动等方面实现。  相似文献   

16.
目的研究突触素(SY)在慢传输型便秘(STC)患者肠神经系统中的表达情况。方法选择肠道造影提示有结肠痉挛并经手术证实STC者20例,取其乙状结肠(痉挛段)及横结肠(近端非痉挛段)肠壁标本为实验组;无结肠痉挛的STC患者20例,取其乙状结肠及横结肠肠壁标本为对照组。2组标本均进行免疫组化检测,分析突触素在STC患者结肠壁的表达情况。结果突触素在2组便秘患者结肠壁肌层的表达均比黏膜下层表达增高(P0.05),实验组的横结肠黏膜下层突触素的表达明显低于对照组(P0.05),其余组间突触素的表达差异无统计学意义。结论 STC患者横结肠与乙状结肠结肠壁肌层突触素的表达均明显高于黏膜下层的表达,与其生理功能相一致。乙状结肠痉挛的发生与突触素的表达水平无相关。突触素在结肠痉挛区近端横结肠黏膜下层的表达减少,可能与其远端乙状结肠肠管持续痉挛导致其近端横结肠发生进行性退变引起代偿性、继发性肠管扩大肥厚造成的肠管扩张和蠕动减弱相关。  相似文献   

17.
Ma WH  Li YH  Gao XQ  Luo YX  Chen S  Wang XT  Wen KH 《中国针灸》2010,30(10):849-852
目的:探寻电针辅助麻醉中可达到最佳麻醉效果的电针频率。方法:将60例择期甲状腺手术患者随机分为A、B、C组,每组20例。A组选用2Hz/100Hz疏密波刺激,B组选用2Hz/15Hz疏密波刺激,C组为不接电针的对照组。刺激双侧合谷、内关穴。针刺诱导15min后行颈丛神经阻滞。观察各组镇痛效果,比较各组患者在麻醉前(T1)、诱导后切皮前(T2)、术中牵拉甲状腺时(T3)、术毕(T4)4个时间点血浆皮质醇(COR)、β-内啡肽(β-EP)浓度的变化。结果:镇痛效果显著率以B组(80.0%,16/20)为最高,A组(50.0%,10/20)居中,C组(10.0%,2/20)最低。T2时间点A组COR含量最高;T3时间点B组COR含量最低。术毕时3组COR含量均达到最高水平,仍然以B组最低。B组血浆β-EP在T3、T4两个时间点较前明显降低(均P0.05)。结论:在电针辅助麻醉中2Hz/15Hz的疏密波刺激频率比2Hz/100Hz的麻醉效果更佳,更能抑制手术麻醉带来的应激反应。  相似文献   

18.
目的探讨慢传输型便秘与中医"血瘀"的关系。方法造模组予大黄颗粒剂灌胃建立慢传输型便秘模型,对照组予同体积的蒸馏水灌胃;通过激光多普勒血流仪探针插入活体大鼠肛门内,比较两组大鼠的肠黏膜血流灌注量和血流速度;硝酸还原酶法测大鼠血清NO,酶联免疫吸附试验法(ELISA)检测大鼠血清内皮素的水平,通过观察两组血清一氧化氮(NO)含量和内皮素含量水平,探讨慢传输便秘与血瘀的关系。结果造模组肠黏膜血流灌注量、血流速度与对照组有显著性差异(P<0.05),且造模组明显高于对照组;造模组首次黑便排出时间与对照组有显著性差异(P<0.05),且造模组明显长于对照组;造模组血清NO、内皮素(ET1)与实验组均有显著性差异(P<0.05)。结论慢传输型便秘模型造模成功,且慢传输便秘与血瘀有关系。  相似文献   

19.

Objective

To observe the effects of electroacupuncture (EA) of three different frequencies (2 Hz, 80 Hz and 2 Hz/80 Hz) on the free radicals in hippocampus of vascular dementia (VD) model mice.

Methods

A total of 100 Kunming mice were randomly divided into a sham operation group, a model group, a 2 Hz EA group, an 80 Hz EA group and a 2 Hz/80 Hz EA group, with 20 mice in each group. The ischemia-reperfusion VD model was established by repeated blockade of bilateral common carotid arteries. Mice in EA groups began EA treatment on the 4th day after the operation. Baihui (GV 20), Dazhui (GV 14), Geshu (BL 17) and Zusanli (ST 36) were punctured and then connected to EA instrument, with different waves of 2 Hz, 80 Hz or 2 Hz/80 Hz (10 min/time) applied accordingly, once a day. During the jumping stand experiment, the learning performance, memory performance and hippocampal calcitonin gene-related peptide (CGRP), nitric oxide synthase (NOS), malondialdehyde (MDA), changes in superoxide dismutase (SOD) and true choline esterase (TChE) were observed. In hippocampus, the CGRP level was determined by radioimmunoassay; the MDA level was determined by thiobarbituric acid colorimetric method; the activities of NOS and TChE were determined by spectrophotometry; the activity of SOD was determined by xanthine oxidase method.

Results

Compared with the sham operation group, the performances of learning and memory decreased significantly in the model group (P<0.01); in hippocampus, the CGRP level decreased, the MDA level increased, the activities of NOS and TChE increased, and the activity of SOD decreased in the model group. Compared with the model group, the learning and memory performances of the EA groups were significantly improved (P<0.05 or P<0.01); in hippocampus, the CGRP level increased, the MDA level decreased, the NOS and TChE activities decreased, and the SOD activity increased (P<0.05 or P<0.01). Among EA groups, the 2 Hz/80 Hz EA group was superior to the 2 Hz EA group and the 80 Hz EA group (P<0.05 or P<0.01).

Conclusion

EA can improve the cognitive impairment of mice with ischemia-reperfusion VD. The mechanism may be related to the improvement of cerebral blood circulation, regulation of the central neurotransmitters, fighting lipid peroxidation and promoting nerve cell repair. The therapeutic effects of EA with different frequencies were different, and the intervention effect by EA at 2 Hz/80Hz is the most significant.
  相似文献   

20.
The aim of this study was to investigate the effects of electroacupuncture (EA) on the glycoconjugate (GC) changes in articular cartilage in the ankle of an arthritic model. Arthritis was induced by an intraplantar injection of complete Freund's adjuvant (CFA) into the hindpaw of male Sprague-Dawley rats. Bilateral EA stimulation at 2 Hz, 15 Hz and 120 Hz was applied at those acupoints corresponding to Zusanli and Sanyinjiao in man, using needles for 3-day intervals for 30 days. To determine the presence of arthritis, paw edema was measured by a water displacement plethysmometer. Edema of the hindpaw induced by CFA-injection was strongly inhibited by EA stimulation throughout the experimental period. At 30 days after CFA-injection, GC changes of articular cartilage of the ankle joint were observed using conventional and lectin histochemistry. The CFA-injected rat revealed general reduction of staining abilities and lectin affinities for GC in comparison with normal rats. Significant reductions of neutral and acidic GC were observed in interterritorial matrix and chondrocyte capsules, respectively. All lectin affinities examined except DBA were also decreased in CFA-injected rats compared to normal ones. However, EA-treated rats, showed similar staining patterns and lectin affinities for GC as to normal ones, especially neutral GC in interterritorial matrix and sWGA and RCA-1 affinities in chondrocytes. It is concluded that EA in all frequencies examined, especially 2 Hz, can attenuate inflammatory edema in CFA-injected rats through alleviation of alterations of GC components in articular cartilage.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号